Terminated PHASE3 INTERVENTIONAL NCT00332826

Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma

A Phase 3, 12-month Treatment, Multicenter, Randomized, Open-Label, Parallel Group Clinical Trial Comparing Prandial Subcutaneous Insulin With Prandial Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma

Sponsor: Mannkind Corporation

Conditions Asthma Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2

Interventions Technosphere Insulin

Updated 7 times since 2017 Last updated: May 3, 2012 Started: Jun 30, 2006 Primary completion: Oct 31, 2007 Completion: Oct 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Non-safety related business decision to combine special population protocols

Other terminated trials from Mannkind Corporation

More terminations from Mannkind Corporation

Other Asthma trials with similar outcome

Browse all Asthma trials

This PHASE3 trial investigates Asthma and Diabetes Mellitus, Type 1 and is currently terminated or withdrawn. Mannkind Corporation leads this study, which shows 7 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE3
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Terminated PHASE3
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE3

First recorded

Jun 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mannkind Corporation

Data source: Mannkind Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Atlanta, United States , Baltimore, United States , Barcelona, Spain , Bialystock, Poland , Bialystok, Poland , Billings, United States , Brampton, Canada , Buena Park, United States , Buenos Aires, Argentina , Cambridge, United Kingdom and 46 more locations